SAM L. BARKER - 15 Jun 2021 Form 4 Insider Report for Cyclacel Pharmaceuticals, Inc. (CYCC)

Role
Director
Signature
/s/ Sam L. Barker
Issuer symbol
CYCC
Transactions as of
15 Jun 2021
Net transactions value
$0
Form type
4
Filing time
17 Jun 2021, 16:08:23 UTC
Next filing
25 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYCC Common Stock Award $0 +2,374 +19783% $0.000000 2,386 15 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYCC Stock Option (right to buy) Award $0 +4,748 $0.000000 4,748 15 Jun 2021 Common Stock 4,748 $6.69 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person received an award of 2,374 restricted stock units on June 15, 2021, which shall vest in full on June 15, 2022.
F2 These options were granted to Dr. Barker for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney